Number 10 launches aviation charm offensive after Burnham third runway remarks October 10, 2026 Andy Burnham’s Downing Street operation has been privately reassuring members of the aviation sector of its support for Heathrow’s third runway expansion, despite the Prime Minister refusing to give the megaproject his backing in a string of media appearances over Labour party conference. City AM understands that Number 10 has been trying to patch up [...]
Verdant Rock Receives A (low) Financial Strength Rating from Morningstar DBRS, Adding a Second International Investment-Grade Assessment October 9, 2026 Verdant Rock now holds Financial Strength Ratings from both Fitch Ratings and Morningstar DBRS, providing counterparties with dual-agency confirmation and reinforcing the security architecture behind each financial guarantee
Former City trader’s rate rigging conviction overturned October 9, 2026 A former City trader previously convicted of rigging the Euribor interest rates has had his fraud conviction overturned. Christian Bittar, formerly a trader at Deutsche Bank, had his conviction overturned by the Court of Appeal on Friday after being sentenced to five years in prison for rigging the primary European interest rate, the Euro Interbank [...]
On this day in 1966: David Cameron is born October 9, 2026 As David Cameron turns 60, Eliot Wilson takes a look back at the life so far of the "chillaxed" Prime Minister.
Revolut boss says US primary listing was ‘always the target’ October 9, 2026 The boss of Revolut has said a primary listing in New York was “always” the company’s top goal, in a snub to the London Stock Exchange after a years-long charm offensive. Nik Storonsky, the founder and chief executive of Revolut, said a primary listing in the US was “always the target, given the deep liquidity [...]
TA Portfolio Company Rocscience to be Acquired by Hexagon October 9, 2026 TA Associates (“TA”), a leading global private equity firm, today announced that its portfolio company Rocscience (“the Company”), a global leader in geotechnical and engineering software solutions, has entered into an agreement to be acquired by Hexagon AB (“Hexagon”) at an enterprise value of approximately $535 million. Upon completion of the transaction, TA will fully [...]
Ascensia Announces Strategic Partnership with Sava for Innovative Microsensor Technology October 9, 2026 Ascensia Diabetes Care, a global diabetes care company and subsidiary of PHC Holdings Corporation (TYO 6523), today announced a strategic partnership with venture-backed health technology startup Sava Technologies to support the introduction and future commercialization of its innovative wearable microsensor. The partnership comprises an exclusive commercialization and distribution agreement, initially in Europe, and a concurrent [...]
Allegion Schedules Webcast to Announce 2026 Third-Quarter Results October 8, 2026 Allegion plc (NYSE: ALLE), a leading global security products and solutions provider, will release its 2026 third-quarter financial results on Thursday, Oct. 22, before the market opens. Later that morning, John H. Stone, president and CEO, and Mike Wagnes, senior vice president and chief financial officer, will conduct a conference call for analysts and investors, [...]
Businesses could face flood of ‘trivial’ compensation claims over GDPR worries October 8, 2026 Businesses could face a “raft” of “trivial” data protection claims if the Supreme Court rules compensation can be won for emotional distress or anxiety caused by data breaches without needing to prove any harm actually occurred, in a hearing set to conclude on Thursday. The case was originally brought by 432 current and former police [...]
AviadoBio Presents New Safety and Biomarker Data from the Phase 1/2 ASPIRE-FTD Trial at the International Conference on Frontotemporal Dementias October 8, 2026 Evolving biomarker data show early signs of dose-dependent increase in cerebrospinal fluid (CSF) progranulinSerum neurofilament light chain (NfL) at/below baseline in all patients with 52-week dataAVB-101 continues to be well tolerated, with no serious adverse events related to treatment to date and no immunosuppression required